Pigmentation Disorder Treatment Market
The pigmentation disorder treatment market is estimated to reach $1,220.91 million by 2031, growing at a CAGR of 4.3% from 2022 to 2031.
PORTLAND, OREGON, UNITED STATES, May 17, 2023 /EINPresswire.com/ — Pigmentation disorder treatment refers to the medical or cosmetic interventions aimed at addressing and managing disorders that affect the coloration of the skin, hair, or eyes. Pigmentation disorders can manifest as either hyperpigmentation (excessive darkening) or hypopigmentation (loss of color). These conditions can be caused by various factors, such as genetic predisposition, hormonal changes, exposure to sunlight, certain medications, autoimmune diseases, or trauma.
CAGR: 4.3%
• Current Market Size: USD 799.79 Million
• Forecast Growing Region: APAC
• Largest Market: North America
• Projection Time: 2021- 2031
• Base Year: 2021
𝐆𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 2023 𝐕𝐞𝐫𝐬𝐢𝐨𝐧 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 – https://www.alliedmarketresearch.com/request-sample/11594
The pigmentation disorder treatment market was valued at $799.79 million in 2021, and is estimated to reach $1,220.91 million by 2031, growing at a CAGR of 4.3% from 2022 to 2031. The pigmentation disorder treatment market growth is driven by increase in patients suffering from pigmentation disorder.
𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐒𝐭𝐮𝐝𝐲
• By type, the vitiligo segment was the highest contributor to the market in 2021.
• By treatment, the corticosteroids segment was the highest contributor to the market in 2021.
• By distribution channel, the hospital pharmacies segment was highest contributor in 2021, and is expected to continue this trend during the forecast period.
• Region wise, North America held the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
North America accounted for a majority of the global pigmentation disorder treatment market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to rise in awareness and prevalence of the pigmentation disorders, and presence of key and robust healthcare infrastructure in the region. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in prevalence of pigmentation disorders, development of healthcare infrastructure and increase in investments projects in the region.
𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (275 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬) @ https://www.alliedmarketresearch.com/pigmentation-disorder-treatment-market/purchase-options
𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬-
Arcutis Biotherapeutics, Inc
Astellas Pharma Inc.
Bausch Health Companies Inc
Dermavant Sciences Inc
Dr. Reddy’s Laboratories Ltd
Galderma S.A
Glenmark Pharmaceuticals Limited
Incyte Corporation
Obagi Cosmeceuticals LLC
Viatris Inc.
𝐇𝐚𝐯𝐞 𝐚 𝐐𝐮𝐞𝐫𝐲? 𝐀𝐬𝐤 𝐎𝐮𝐫 𝐄𝐱𝐩𝐞𝐫𝐭 https://www.alliedmarketresearch.com/purchase-enquiry/11594
𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐅𝐨𝐫 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pigmentation disorder treatment market analysis from 2021 to 2031 to identify the prevailing pigmentation disorder treatment market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the pigmentation disorder treatment market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global pigmentation disorder treatment market trends, key players, market segments, application areas, and market growth strategies.
𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬
𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐓𝐫𝐚𝐧𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧 𝐒𝐨𝐟𝐭𝐰𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/medical-transcription-software-market-A31454
𝐇𝐲𝐩𝐞𝐫𝐛𝐚𝐫𝐢𝐜 𝐎𝐱𝐲𝐠𝐞𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/hyperbaric-oxygen-therapy-market-A15638
𝐕𝐢𝐭𝐢𝐥𝐢𝐠𝐨 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/vitiligo-treatment-market-A31464
David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Article originally published on www.einpresswire.com as Pigmentation Disorder Treatment Market is Projected to Grow Significantly, to Attain a Value of USD 1.2 Billion by 2031